[Sle-saccharides: a promising tool against inflammation].
Renkonen
R
R
Department of Bacteriology and Serology , Haartman Institute, wrsity Department of Bacteriology and Serology, Haartman Institute, rsity of Helsinki, Helsinki, Finland.
Renkonen
O
O
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002448:Cell Adhesion / Q000187:drug effects; D002986:Clinical Trials as Topic; D006086:Graft vs Host Disease / Q000188:drug therapy; D007249:Inflammation / Q000188:drug therapy; D019041:L-Selectin / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D009844:Oligosaccharides / Q000627:therapeutic use*; D015427:Reperfusion Injury / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D009844:Oligosaccharides; D019041:L-Selectin
Sokerit tulossa tulehdusten hoitoon.